Biora Therapeutics, Inc. (NASDAQ: BIOR) reported Q1 EPS of ($1.59), $1.52 worse than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Biora Therapeutics, Inc. (BIOR) click here.